EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A redundant isoprenoid biosynthetic pathway supports Staphylococcus aureus metabolic versatility

Troy A Burtchett, Elizabeth N Ottosen, Tomotaka Jitsukawa, Momoko Kaneko, Miu Yasui, Jessica A Lysne, Paige J Kies, Jessica A Bailey, Sean M Thomas, Shingo Fujisaki, Neal D Hammer iD

mBio · 2025

DOI: 10.1128/mbio.00353-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mBio, 2025. Verfasst von Troy A Burtchett und 10 weiteren Autor:innen. Beteiligte Einrichtung: Microbiology, Genetics, & Immunology, Biomedical & Physical Sciences Building, Michigan State University, East Lansing, Michigan, USA. Hauptthemen laut MEDLINE: Staphylococcus aureus, Terpenes, Biosynthetic Pathways. Die Arbeit nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, Japan Society for the Promotion of Science, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Isoprenoids are ubiquitous molecules that serve as fundamental building blocks for life. In bacteria, isoprenoids are precursors for carotenoid pigments, respiratory cofactors, and essential sugar carrier lipids, such as lipid II. Isoprenoid synthesis initiates via condensation of the five-carbon (C 5 ) precursors, isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP). This initial reaction condenses one DMAPP and two IPPs, resulting in C 15 farnesyl diphosphate (FPP), an intermediate that is sequentially elongated with IPP. FPP is thought to be synthesized exclusively by the prenyl diphosphate synthase (PDS), IspA. In Staphylococcus aureus , ispA mutants lack the golden carotenoid pigment, staphyloxanthin. The fact that ispA can be inactivated in S. aureus and other bacteria is surprising given the reliance of lipid II on FPP and supports the hypothesis that an additional enzyme produces the critical isoprenoid precursor. We isolated pigmented ispA suppressor mutants harboring single-nucleotide polymorphisms within a second PDS-encoding gene, hepT , suggesting that HepT and IspA have overlapping roles in S. aureus isoprenoid synthesis. Subsequent work determined that IspA and HepT support metabolic versatility, as a hepT ispA double mutant fails to aerobically respire partially due to a lack of prenylated heme cofactors. The finding that a hepT ispA double mutant is viable supports a model whereby a third PDS compensates in the absence of ispA and hepT to produce lipid II precursors. Lastly, we show that ispA and hepT mutants exhibit colonization defects in a murine model of systemic infection, demonstrating that isoprenoid biosynthesis is a potential drug target for combating S. aureus . IMPORTANCE Isoprenoid synthesis is an essential process that is presumed to be initiated by the prenyl diphosphate synthase (PDS), IspA. However, our understanding of this pathway is incomplete considering that ispA mutants have been described in several bacterial species, leaving the mechanism for isoprenoid synthesis initiation uncertain in these genetic backgrounds. Using the opportunistic pathogen Staphylococcus aureus , we demonstrate that a second PDS, HepT, supports the production of isoprenoid-dependent molecules in the absence of IspA. Importantly, we show that mutants deficient for either IspA or HepT display colonization defects in a murine model of systemic infection. Furthermore, the simultaneous mutation of hepT and ispA is tolerated in S. aureus and suggests the presence of a third PDS capable of initiating isoprenoid synthesis. This study establishes PDSs as viable targets for the treatment of S. aureus infections and provides novel insights into the redundant nature of isoprenoid synthesis in this pathogen.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Staphylococcus aureusTerpenesBiosynthetic PathwaysAnimalsMiceStaphylococcal InfectionsHemiterpenesDisease Models, AnimalFemaleSesquiterpenesPolyisoprenyl PhosphatesPolymorphism, Single NucleotideOrganophosphorus CompoundsXanthophylls

Stichwörter der Autor:innen

Staphylococcus aureusbacterial respirationfarnesyl diphosphateheme aheme oheptaprenyl diphosphate synthaseisoprenoidmenaquinoneprenyl diphosphate synthaseterminal oxidase

Substanzen

TerpenesstaphyloxanthinHemiterpenesfarnesyl pyrophosphateSesquiterpenesisopentenyl pyrophosphatePolyisoprenyl PhosphatesOrganophosphorus CompoundsXanthophylls

Autor:innen und Institutionen

  • Microbiology, Genetics, & Immunology, Biomedical & Physical Sciences Building, Michigan State University, East Lansing, Michigan, USA.
  • Department of Biomolecular Science, Faculty of Science, Toho University, Funabashi, Chiba, Japan.

ORCID-Profile: Neal D Hammer

Förderung

  • NIH HHS
  • Japan Society for the Promotion of Science
  • NIAID NIH HHS
  • National Institutes of Health

Zitieren

APA

Burtchett, T. A., Ottosen, E. N., Jitsukawa, T., Kaneko, M., Yasui, M., Lysne, J. A., Kies, P. J., Bailey, J. A., Thomas, S. M., Fujisaki, S., & Hammer, N. D. (2025). A redundant isoprenoid biosynthetic pathway supports Staphylococcus aureus metabolic versatility. mBio. https://doi.org/10.1128/mbio.00353-25

Vancouver

Burtchett TA, Ottosen EN, Jitsukawa T, Kaneko M, Yasui M, Lysne JA, et al. A redundant isoprenoid biosynthetic pathway supports Staphylococcus aureus metabolic versatility. mBio. 2025. doi:10.1128/mbio.00353-25

BibTeX
@article{Burtchett2025,
  author = {Burtchett, Troy A and Ottosen, Elizabeth N and Jitsukawa, Tomotaka and Kaneko, Momoko and Yasui, Miu and Lysne, Jessica A and Kies, Paige J and Bailey, Jessica A and Thomas, Sean M and Fujisaki, Shingo and Hammer, Neal D},
  title = {A redundant isoprenoid biosynthetic pathway supports Staphylococcus aureus metabolic versatility},
  journal = {mBio},
  year = {2025},
  doi = {10.1128/mbio.00353-25}
}
Kostenlos starten →